跳至主要内容
临床试验/CTRI/2018/03/012861
CTRI/2018/03/012861招募中2 期

An Open Clinical Study to evaluate the clinical efficacy of siddha sasthric formulation "PANJALAVANA PARPAM"(Internal)"LAHU VATHA KESARI THYLAM " for the treatment of AZHAL KEEL VAYU.

Dr S Neelavathi1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2017年3月8日最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
40
试验地点
1
主要终点
Reduction In Severity Of Joint Pain,Stiffness,And Improvement In Physical Functioning And Quality Of Life

研究概览

简要总结

Phase IIcriteria based clinical study to evaluate the clinical efficacy of siddha herbomineral formulation of Panja lavana parpam 1 Kalanju (5.1Gram) Bd with Â¼ Perungayam added toHoney (Internal) andlahuvatha kesari thylam 30 ml (External) on Azal keel vayu(Osteo arthritis)  for 48 daysin 40 patients during the trial period of 1 year 6 months that will beconducted in government siddha medical college palyamkottai tamil nadu theprimary out come is reducing the clinical symptoms and increasing the range ofmovements of trail drug Panja lavana parpam (Internal) and lahu vatha kesari thylam (external) the secondary outcome will be the Evaluation of siddha diagnosticparameters.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Open Label

入排标准

年龄范围
30.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • 1.patients having symptoms of joint pain in one or both knee 2.joints,swelling,tenderness,stiffness,crepitation,restricted movements of joints.
  • 3.patients who are willing to take x-ray before and after treatment.
  • 4.patients who are willing to participate in this study with knowledge of potential risk.

排除标准

  • 1.systemic illness of the patient 2.Rhematoid arthritis 3.Use of narcotic drug 4.Pregnancy and lactation 5.History of trauma 6.Carcinoma patient Tuberculosis Immuno compromised patients Clinically significant abnormal laboratory values.

结局指标

主要结局

Reduction In Severity Of Joint Pain,Stiffness,And Improvement In Physical Functioning And Quality Of Life

时间窗: 48 days

次要结局

  • Evaluation of siddha diagnostic parameters(48 days)

研究者

发起方
Dr S Neelavathi
申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验